Defence Therapeutics Inc. (CSE:DTC)

Defence Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	2.08	0.06	2.79	0.51	5.45	1.87
Cash & Short-Term Investments	2.08	0.06	2.79	0.51	5.45	1.87
Cash Growth	304.19%	-97.97%	451.20%	-90.71%	192.24%	243493.60%
Other Receivables	0.09	0.1	0.15	0.03	0.07	-
Receivables	0.09	0.1	0.15	0.03	0.07	-
Prepaid Expenses	0	0.06	0.49	0.14	0.04	-
Total Current Assets	2.17	0.21	3.43	0.67	5.56	1.87
Property, Plant & Equipment	0.19	0.26	0.06	-	-	-
Other Intangible Assets	-	-	0.04	0.05	0.05	0.05
Total Assets	2.36	0.48	3.53	0.72	5.61	1.91
Accounts Payable	1.15	2.09	0.19	0.98	0.11	0.05
Short-Term Debt	-	0.05	-	-	-	-
Current Portion of Long-Term Debt	1.38	1.66	-	-	-	-
Current Portion of Leases	0.02	0.03	-	-	-	-
Other Current Liabilities	0.04	0.22	0.03	0.13	0.01	-
Total Current Liabilities	2.58	4.05	0.22	1.11	0.12	0.05
Long-Term Debt	-	-	1.75	-	-	-
Long-Term Leases	-	0.01	-	-	-	-
Total Liabilities	2.58	4.06	1.97	1.11	0.12	0.05
Common Stock	19.93	19.24	16.95	9.33	7.97	2.4
Retained Earnings	-28.31	-29.81	-16.91	-10.52	-3.53	-0.67
Comprehensive Income & Other	8.17	6.98	1.52	0.79	1.05	0.14
Shareholders' Equity	-0.22	-3.58	1.57	-0.39	5.49	1.86
Total Liabilities & Equity	2.36	0.48	3.53	0.72	5.61	1.91
Total Debt	1.39	1.75	1.75	-	-	-
Net Cash (Debt)	0.69	-1.69	1.05	0.51	5.45	1.87
Net Cash Growth	-	-	106.61%	-90.71%	192.24%	243493.60%
Net Cash Per Share	0.01	-0.04	0.03	0.01	0.21	1.98
Filing Date Shares Outstanding	54.73	45.54	44.27	37.68	35.96	18.47
Total Common Shares Outstanding	54.73	45.54	43.78	36.63	35.22	18.47
Working Capital	-0.41	-3.84	3.21	-0.43	5.44	1.82
Book Value Per Share	-0.00	-0.08	0.04	-0.01	0.16	0.10
Tangible Book Value	-0.22	-3.58	1.53	-0.43	5.44	1.82
Tangible Book Value Per Share	-0.00	-0.08	0.03	-0.01	0.15	0.10
Machinery	0.25	0.27	0.07	-	-	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.